Prophylaxis and therapy of experimental ocular herpes simplex. Comparison of idoxuridine, adenine arabinoside, and hypoxanthine arabinoside.
D000225:Adenine / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001089:Arabinose / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D007042:Hypoxanthines / Q000008:administration & dosage / Q000627:therapeutic use; D007065:Idoxuridine / Q000008:administration & dosage / Q000627:therapeutic use*; D007635:Keratitis, Dendritic / Q000188:drug therapy* / Q000517:prevention & control; D007637:Keratoconjunctivitis / Q000188:drug therapy* / Q000517:prevention & control; D008297:Male; D009705:Nucleosides / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D011817:Rabbits
D000998:Antiviral Agents; D007042:Hypoxanthines; D009705:Nucleosides; D010919:Placebos; D001089:Arabinose; D000225:Adenine; D007065:Idoxuridine